• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因胸苷酸合成酶缺乏而筛选出的人结肠腺癌突变体。

Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.

作者信息

Houghton P J, Germain G S, Hazelton B J, Pennington J W, Houghton J A

机构信息

Department of Biochemical and Clinical Pharmacology, Saint Jude Children's Research Hospital, Memphis, TN 38101.

出版信息

Proc Natl Acad Sci U S A. 1989 Feb;86(4):1377-81. doi: 10.1073/pnas.86.4.1377.

DOI:10.1073/pnas.86.4.1377
PMID:2537495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC286693/
Abstract

GC3/c1 human colon adenocarcinoma cells were treated with the mutagen ethyl methanesulfonate, and three clones deficient in thymidylate synthase (5,10-methylenetetrahydrofolate:dUMP C-methyltransferase, EC 2.1.1. 45) activity were selected and characterized. Growth in medium deficient in thymidine caused cell death in two clones (TS- c1 and TS- c3), whereas one clone (TS- c2) showed limited growth. Growth correlated with thymidine synthase activity and 5-fluoro-2'-deoxyuridine 5'-monophosphate-binding capacity and with incorporation of 2'-deoxy[6-3H]uridine into DNA. In the presence of optimal thymidine, growth rates were only 5-18% that of the parental clone (GC3/c1), which grew equally well in thymidine-deficient or -replete medium. Analysis of poly(A)+ RNA showed normal levels of a 1.6-kilobase transcript in TS- c1 and TS- c2 but decreased levels (approximately 6% control) in TS- c3. Clone TS- c3 was 32-, 750-, and greater than 100,000-fold more resistant than the parental clone to 5-fluorouracil, 5-fluoro-2'-deoxyuridine, and methotrexate, respectively. When inoculated into athymic nude mice, each TS- clone produced tumors, demonstrating continued ability to proliferate in vivo.

摘要

用诱变剂甲磺酸乙酯处理GC3/c1人结肠腺癌细胞,筛选并鉴定出三个胸苷酸合成酶(5,10-亚甲基四氢叶酸:dUMP C-甲基转移酶,EC 2.1.1.45)活性缺陷的克隆。在缺乏胸苷的培养基中生长导致两个克隆(TS-c1和TS-c3)细胞死亡,而一个克隆(TS-c2)生长受限。生长与胸苷合成酶活性、5-氟-2'-脱氧尿苷5'-单磷酸结合能力以及2'-脱氧[6-³H]尿苷掺入DNA相关。在最佳胸苷存在的情况下,生长速率仅为亲本克隆(GC3/c1)的5%-18%,亲本克隆在缺乏胸苷或富含胸苷的培养基中生长情况相同。对多聚腺苷酸加尾RNA(poly(A)+ RNA)的分析表明,TS-c1和TS-c2中1.6千碱基转录本水平正常,但TS-c3中水平降低(约为对照的6%)。克隆TS-c3对5-氟尿嘧啶、5-氟-2'-脱氧尿苷和甲氨蝶呤的抗性分别比亲本克隆高32倍、750倍和超过100,000倍。当接种到无胸腺裸鼠体内时,每个TS克隆都产生了肿瘤,表明其在体内仍具有增殖能力。

相似文献

1
Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.因胸苷酸合成酶缺乏而筛选出的人结肠腺癌突变体。
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1377-81. doi: 10.1073/pnas.86.4.1377.
2
Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.人腺癌细胞胸苷酸合成酶基因的突变导致胸苷酸合成酶阴性表型,该表型可被外源性叶酸减弱。
Cancer Res. 1992 Feb 1;52(3):558-65.
3
Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line.一种胸苷酸合成酶缺陷型人结肠肿瘤细胞系的分离与鉴定
Biochem Pharmacol. 1999 Nov 15;58(10):1529-37. doi: 10.1016/s0006-2952(99)00237-3.
4
Development and characterization of a human colon adenocarcinoma xenograft deficient in thymidine salvage.一种胸苷补救缺陷型人结肠腺癌异种移植模型的建立与特性分析
Cancer Res. 1987 Apr 15;47(8):2117-22.
5
Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.γ干扰素与5-氟尿嘧啶在H630人结肠癌细胞系中的相互作用。
Cancer Res. 1990 Sep 15;50(18):5834-40.
6
Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.胸苷酸合成酶缺陷型小鼠FM3A乳腺癌细胞系作为研究胸苷补救途径以及胸苷类似物掺入宿主细胞DNA的工具。
Biochem J. 1984 Jan 1;217(1):245-52. doi: 10.1042/bj2170245.
7
Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR.通过竞争性聚合酶链反应检测和定量人结肠腺癌细胞系中对5-氟尿嘧啶耐药的胸苷酸合成酶信使核糖核酸
Anticancer Res. 1998 May-Jun;18(3A):1457-63.
8
Mutants of Chinese hamster cells deficient in thymidylate synthetase.胸苷酸合成酶缺陷的中国仓鼠细胞突变体。
J Cell Physiol. 1984 Aug;120(2):109-16. doi: 10.1002/jcp.1041200202.
9
Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.结肠异种移植中的生化机制:胸苷酸合成酶作为治疗靶点
Invest New Drugs. 1989 Apr;7(1):59-69. doi: 10.1007/BF00178192.
10
[Detection of thymidylate synthase mRNA in 5-fluorouracil resistant human colon adenocarcinoma cells].[5-氟尿嘧啶耐药人结肠腺癌细胞中胸苷酸合成酶mRNA的检测]
Gan To Kagaku Ryoho. 1994 Aug;21(10):1613-8.

引用本文的文献

1
Formation of catalytically active cross-species heterodimers of thymidylate synthase from Plasmodium falciparum and Plasmodium vivax.恶性疟原虫和间日疟原虫胸苷酸合成酶的催化活性种间异二聚体的形成。
Mol Biol Rep. 2011 Feb;38(2):1029-37. doi: 10.1007/s11033-010-0199-7. Epub 2010 Jun 25.
2
Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.胸苷与1843U89(一种基于叶酸的胸苷酸合成酶抑制剂)联合使用对恶性疟原虫具有强效和选择性活性。
Antimicrob Agents Chemother. 2000 Apr;44(4):1047-50. doi: 10.1128/AAC.44.4.1047-1050.2000.
3

本文引用的文献

1
Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer.哺乳动物细胞的体外克隆生长;有无饲养层时单个海拉细胞形成的集落的生长特性。
J Exp Med. 1956 Feb 1;103(2):273-83. doi: 10.1084/jem.103.2.273.
2
Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.小鼠体内人大肠腺癌异种移植瘤对5-氟尿嘧啶及其衍生物反应性的生化决定因素
Cancer Res. 1981 Jan;41(1):144-9.
3
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains.
恶性疟原虫胸苷酸合成酶与二氢叶酸还原酶结构域之间的必需蛋白质-蛋白质相互作用。
J Biol Chem. 1999 Dec 31;274(53):37781-6. doi: 10.1074/jbc.274.53.37781.
4
Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694.恶性疟原虫胸苷酸合成酶的动力学:与5-氟乳清酸和D1694的高亲和力代谢物的相互作用
Antimicrob Agents Chemother. 1996 Jul;40(7):1628-32. doi: 10.1128/AAC.40.7.1628.
5
Pyrimidine metabolism by intracellular Chlamydia psittaci.鹦鹉热衣原体的胞内嘧啶代谢
J Bacteriol. 1993 Aug;175(15):4652-61. doi: 10.1128/jb.175.15.4652-4661.1993.
6
Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.5-氟乳清酸在人类疟原虫恶性疟原虫中的分子靶点
Antimicrob Agents Chemother. 1992 Apr;36(4):704-11. doi: 10.1128/AAC.36.4.704.
一种强效的胸苷酸合成酶喹唑啉类抗肿瘤抑制剂:合成、生物学特性及对小鼠的治疗效果
Eur J Cancer (1965). 1981 Jan;17(1):11-9. doi: 10.1016/0014-2964(81)90206-1.
4
Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase.胸苷酸合成酶缺陷的小鼠FM3A细胞突变体的一步筛选。
Somatic Cell Genet. 1980 Mar;6(2):261-70. doi: 10.1007/BF01538800.
5
Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes.使用特异性克隆的cDNA探针检测α-和β-微管蛋白以及细胞质β-和γ-肌动蛋白基因的数量和进化保守性。
Cell. 1980 May;20(1):95-105. doi: 10.1016/0092-8674(80)90238-x.
6
Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.5,8-二去氮异喋呤谷氨酸(一种独特的胸苷酸合成酶喹唑啉抑制剂)的生化及抗肿瘤作用
Cancer Res. 1983 Mar;43(3):1117-23.
7
Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle.纽蛋白与一种分子量更高的类纽蛋白在平滑肌中的共存。
J Biol Chem. 1982 Sep 25;257(18):11024-31.
8
Chromosome breakage induced by thymidylate stress in thymidylate synthase-negative mutants of mouse FM3A cells.胸苷酸合成酶阴性的小鼠FM3A细胞突变体中,胸苷酸应激诱导的染色体断裂。
Cancer Res. 1984 Feb;44(2):703-9.
9
Mutants of Chinese hamster cells deficient in thymidylate synthetase.胸苷酸合成酶缺陷的中国仓鼠细胞突变体。
J Cell Physiol. 1984 Aug;120(2):109-16. doi: 10.1002/jcp.1041200202.
10
Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle.从单层培养的细胞中制备细胞核,适用于计数以及跟踪同步化细胞通过细胞周期。
Anal Biochem. 1984 Aug 15;141(1):70-3. doi: 10.1016/0003-2697(84)90426-3.